# Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure

> **NCT05613140** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 9230 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** sacubitril/valsartan

## Key facts

- **NCT ID:** NCT05613140
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-02
- **Primary completion:** 2021-11-05
- **Final completion:** 2021-11-05
- **Target enrollment:** 9230 (ACTUAL)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05613140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05613140, "Sacubitril/Valsartan Treated Adult Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05613140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*